Foschini MP et al. have shown that MAGEA family members are hypomethylated in male breast cancer (MBC), leading to their over-expression, which enhances the androgen receptor (AR) activity and AR therapy response [22]. The gene discussed is AR; the disease is male breast carcinoma.